Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP13577.RA0FGkz8EmNWU4QhkkNnaQMczgmtG2uxYyT8PXTrNSyaE130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP13577.RA0FGkz8EmNWU4QhkkNnaQMczgmtG2uxYyT8PXTrNSyaE130_provenance.
• NP13576.RACZ7dMxUqyllMCkUlKSj_TfEm0817V5yOKgKzytzfQII130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP13576.RACZ7dMxUqyllMCkUlKSj_TfEm0817V5yOKgKzytzfQII130_provenance.
• NP8737.RAquN42ygp27UhDqWI9uHhqsLD5evaY2vIw6wsDz1LnHc130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8737.RAquN42ygp27UhDqWI9uHhqsLD5evaY2vIw6wsDz1LnHc130_provenance.
• NP8736.RAVL6rm8IOqM0ZRBEeEi4xmTKB0Xe9NRpPEXd_6GQCYvk130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8736.RAVL6rm8IOqM0ZRBEeEi4xmTKB0Xe9NRpPEXd_6GQCYvk130_provenance.
• assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP240249.RAakoZnai3hdTey8Y4Q_HubxinZTQZgFbAHjBZBwgJe5U130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240249.RAakoZnai3hdTey8Y4Q_HubxinZTQZgFbAHjBZBwgJe5U130_provenance.
• assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP581572.RAWlp1dU52Y1TiyQ_9_Od35iRV93vbHNQsroW0Lu3qw8o130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581572.RAWlp1dU52Y1TiyQ_9_Od35iRV93vbHNQsroW0Lu3qw8o130_provenance.
• NP581558.RAgxZZS4yYNapsnj9XdPE8Pm_EJQDb6G5rtXJn_BiFWYE130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581558.RAgxZZS4yYNapsnj9XdPE8Pm_EJQDb6G5rtXJn_BiFWYE130_provenance.
• NP347337.RA-cmh0EnbpRjBakIyLoFJ6UcETYeIofHpgGTs7E8RWK8130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347337.RA-cmh0EnbpRjBakIyLoFJ6UcETYeIofHpgGTs7E8RWK8130_provenance.
• NP752589.RAHE5ho5Olud2mI9NHsnju9N_6QrNBC_9xw_IRSljfV40130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752589.RAHE5ho5Olud2mI9NHsnju9N_6QrNBC_9xw_IRSljfV40130_provenance.
• NP581555.RAPBze7_87JC2xVoZkt-YYk3QnbyJ_6C623qQUpCf72Kw130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581555.RAPBze7_87JC2xVoZkt-YYk3QnbyJ_6C623qQUpCf72Kw130_provenance.
• NP758716.RAwUP3T7VqGsQWME-3k7gAdZEAW9ismKjyI6JjrmJMiEI130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758716.RAwUP3T7VqGsQWME-3k7gAdZEAW9ismKjyI6JjrmJMiEI130_provenance.
• NP759437.RA5xQ3k9XWBL9mNtm32Ol5T0Dn92FWhkVrnwaD1IK9GqU130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759437.RA5xQ3k9XWBL9mNtm32Ol5T0Dn92FWhkVrnwaD1IK9GqU130_provenance.
• NP581556.RA2PeoDHJsE8DERYCGmk17epdfRpAmKMNmL1JyJk3UxTU130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581556.RA2PeoDHJsE8DERYCGmk17epdfRpAmKMNmL1JyJk3UxTU130_provenance.
• NP581563.RA1xASWoVN-_h08cLlBhNsVuSp6KSEQuVbqRFqCGzdIUc130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581563.RA1xASWoVN-_h08cLlBhNsVuSp6KSEQuVbqRFqCGzdIUc130_provenance.
• NP581566.RA_YT9vYr9aISXA1fsD-USdG3pxCKgKk6D7MeQwZTFa8M130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581566.RA_YT9vYr9aISXA1fsD-USdG3pxCKgKk6D7MeQwZTFa8M130_provenance.
• NP581568.RA9DksAd2bVLwJ0MXXBNzomUFq1mKiBOK6QHVsXPobTNU130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581568.RA9DksAd2bVLwJ0MXXBNzomUFq1mKiBOK6QHVsXPobTNU130_provenance.
• NP581570.RA8s3m6SpMw8qDTQp8FVQwNjr-7foIqJsu3iOGATpCSCE130_assertion description "[To examine the significance of the methylation level of the p53 target and tumour suppressor genes apoptotic protease activating factor-1 (APAF-1) and death-associated protein kinase-1 (DAPK-1) in 80 microdissected tumour samples from transitional cell carcinoma (TCC) of the bladder and 80 tumour samples from clear-cell renal cell carcinoma (RCC) as well as from non-tumourous bladder and kidney tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581570.RA8s3m6SpMw8qDTQp8FVQwNjr-7foIqJsu3iOGATpCSCE130_provenance.